LOOMIS SAYLES & CO L P – Supernus Pharmaceuticals, Inc. Transaction History
LOOMIS SAYLES & CO L P portfolio value:
$54.20M
portfolio value
LOOMIS SAYLES & CO L P quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.60% | -9.65K shares | 7.61M | $33.85 | 1.60M |
| Q2 2022 | share | Decrease | -1.15% | -18.69K shares | -6.08M | $28.92 | 1.61M |
| Q1 2022 | share | Decrease | -2.49% | -41.55K shares | 3.93M | $32.32 | 1.62M |
| Q4 2021 | share | Increase | +1.25% | 20.64K shares | 4.71M | $30.03 | 1.67M |
| Q3 2021 | share | Increase | +1.95% | 31.50K shares | -5.83M | $26.67 | 1.65M |
| Q2 2021 | share | Increase | +274.50% | 1.18M shares | 38.53M | $30.79 | 1.61M |
| Q1 2021 | share | Increase | +23.48% | 82.19K shares | 2.50M | $26.18 | 432.32K |
| Q4 2020 | share | Decrease | -3.28% | -11.87K shares | 1.26M | $25.16 | 350.12K |
| Q3 2020 | share | Decrease | -0.41% | -1.5K shares | -1.08M | $20.84 | 362.00K |
| Q2 2020 | share | Decrease | -3.27% | -12.26K shares | 1.87M | $23.75 | 363.50K |
| Q1 2020 | share | Decrease | -40.76% | -258.53K shares | -8.28M | $17.99 | 375.77K |
| Q4 2019 | share | Decrease | -43.19% | -482.26K shares | -15.63M | $23.72 | 634.30K |
| Q3 2019 | share | Increase | +11.28% | 113.13K shares | -2.52M | $27.48 | 1.11M |
| Q2 2019 | share | Increase | +136.03% | 578.30K shares | 18.30M | $33.09 | 1.00M |
| Q1 2019 | share | Decrease | -4.25% | -18.85K shares | 147K | $35.04 | 425.12K |
| Q4 2018 | share | Decrease | -22.54% | -129.22K shares | -14.11M | $33.22 | 443.98K |
| Q3 2018 | share | Decrease | -1.11% | -6.46K shares | -5.83M | $50.35 | 573.21K |
| Q2 2018 | share | Increase | +0.98% | 5.61K shares | 8.40M | $59.85 | 579.67K |
| Q1 2018 | share | Decrease | -3.42% | -20.34K shares | 2.60M | $45.8 | 574.05K |
| Q4 2017 | share | Decrease | -8.33% | -54.01K shares | -2.24M | $39.85 | 594.39K |
| Q3 2017 | share | Decrease | -2.93% | -19.58K shares | -2.85M | $40 | 648.40K |
| Q2 2017 | share | Decrease | -3.28% | -22.63K shares | 7.17M | $43.1 | 667.98K |
| Q1 2017 | share | Decrease | -2.20% | -15.53K shares | 3.78M | $31.3 | 690.62K |
| Q4 2016 | share | Decrease | -4.92% | -36.54K shares | -536K | $25.25 | 706.16K |
| Q3 2016 | share | Decrease | -2.68% | -20.42K shares | 2.82M | $24.73 | 742.70K |
| Q2 2016 | share | Increase | +96990.08% | 762.34K shares | 15.53M | $20.37 | 763.12K |
| Q1 2016 | share | Increase | +222.13% | 542 shares | 9K | $15.25 | 786 |